Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Tardive dyskinesia: clinical presentation and treatment.

van Harten PN, Tenback DE.

Int Rev Neurobiol. 2011;98:187-210. doi: 10.1016/B978-0-12-381328-2.00008-0. Review.

PMID:
21907088
2.

Treatment of intractable tardive lingual dyskinesia with botulinum toxin.

Beckmann YY, Seçil Y, Saka S, Kuserli A, Çiftçi Y.

J Clin Psychopharmacol. 2011 Apr;31(2):250-1. doi: 10.1097/JCP.0b013e31820f4f70. No abstract available.

PMID:
21364341
3.

Surgery for tardive dyskinesia.

Thobois S, Poisson A, Damier P.

Int Rev Neurobiol. 2011;98:289-96. doi: 10.1016/B978-0-12-381328-2.00012-2. Review.

PMID:
21907092
4.

Flupenthixol-induced tardive dystonia presenting as severe dysphagia.

Agarwal PA, Ichaporia NR.

Neurol India. 2010 Sep-Oct;58(5):784-5. doi: 10.4103/0028-3886.72168. No abstract available.

5.

Tardive dystonia.

van Harten PN, Kahn RS.

Schizophr Bull. 1999;25(4):741-8. Review.

PMID:
10667744
6.

Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Cloud LJ, Zutshi D, Factor SA.

Neurotherapeutics. 2014 Jan;11(1):166-76. doi: 10.1007/s13311-013-0222-5.

7.

Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.

Hennings JM, Krause E, Bötzel K, Wetter TC.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1167-71. Epub 2007 Sep 18. Review.

PMID:
17936461
8.

[Treatment of tardive syndromes].

Horváth K, Aschermann Z, Komoly S, Kovács A, Kovács N.

Psychiatr Hung. 2014;29(2):214-24. Review. Hungarian.

PMID:
25041749
9.

Tardive dyskinesia: eliminated, forgotten, or overshadowed?

Remington G.

Curr Opin Psychiatry. 2007 Mar;20(2):131-7. Review.

PMID:
17278910
10.

[Severe treatment-resistant tardive dystonia: is deep brain stimulation a treatment option].

Mentzel CL, Tenback DE, Tijssen MA, van Harten PN.

Tijdschr Psychiatr. 2015;57(2):125-31. Dutch.

11.

Tardive drug-induced extrapyramidal syndromes.

Marsálek M.

Pharmacopsychiatry. 2000 Sep;33 Suppl 1:14-33. Review.

PMID:
11072762
12.

Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Caligiuri MR, Jeste DV, Lacro JP.

Drugs Aging. 2000 Nov;17(5):363-84. Review.

PMID:
11190417
13.

Classification and treatment of tardive syndromes.

Fernandez HH, Friedman JH.

Neurologist. 2003 Jan;9(1):16-27. Review.

PMID:
12801428
14.

[Treatment of non-dopamine-dependent signs in parkinsonian syndromes: evaluation and results].

Tardieu S, Becker H, Micallef J, Blin O.

Rev Neurol (Paris). 2003 May;159(5 Pt 2):3S87-92. Review. French.

PMID:
12773893
15.

Animal models of tardive dyskinesia.

Kulkarni SK, Dhir A.

Int Rev Neurobiol. 2011;98:265-87. doi: 10.1016/B978-0-12-381328-2.00011-0. Review.

PMID:
21907091
16.

The role of serotonin in the antidyskinetic effects of deep brain stimulation: focus on antipsychotic-induced motor symptoms.

Creed MC, Nobrega JN.

Rev Neurosci. 2013;24(2):153-66. doi: 10.1515/revneuro-2012-0083. Review.

PMID:
23399586
17.

Botulinum toxin as an effective treatment of clozapine-induced hypersalivation.

Kahl KG, Hagenah J, Zapf S, Trillenberg P, Klein C, Lencer R.

Psychopharmacology (Berl). 2004 Apr;173(1-2):229-30. Epub 2004 Jan 28.

PMID:
14747903
18.

Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.

Damier P, Thobois S, Witjas T, Cuny E, Derost P, Raoul S, Mertens P, Peragut JC, Lemaire JJ, Burbaud P, Nguyen JM, Llorca PM, Rascol O; French Stimulation for Tardive Dyskinesia (STARDYS) Study Group.

Arch Gen Psychiatry. 2007 Feb;64(2):170-6.

PMID:
17283284
19.

[Tardive dyskinesia: diagnosis, assessment and treatment].

Frascarelli M, Paolemili M, Gallo M, Parente F, Biondi M.

Riv Psichiatr. 2013 May-Jun;48(3):187-96. doi: 10.1708/1292.14287. Italian.

PMID:
23752802
20.

Supplemental Content

Support Center